Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Targeting lymphangiogenesis to prevent tumour metastasis Achen MG; Mann GB; Stacker SABr J Cancer 2006[May]; 94 (10): 1355-60Recent studies involving animal models of cancer and clinicopathological analyses of human tumours suggest that the growth of lymphatic vessels (lymphangiogenesis) in or nearby tumours is associated with the metastatic spread of cancer. The best validated molecular signalling system for tumour lymphangiogenesis involves the secreted proteins vascular endothelial growth factor-C (VEGF-C) and VEGF-D that induce growth of lymphatic vessels via activation of VEGF receptor-3 (VEGFR-3) localised on the surface of lymphatic endothelial cells. In this review, we discuss the evidence supporting a role for this signalling system in the spread of cancer and potential approaches for blocking this system to prevent tumour metastasis.|Animals[MESH]|Humans[MESH]|Lymphangiogenesis/*drug effects[MESH]|Lymphatic Metastasis/prevention & control[MESH]|Lymphatic Vessels/physiology[MESH]|Neoplasms/metabolism/pathology/*therapy[MESH]|Vascular Endothelial Growth Factor C/physiology[MESH]|Vascular Endothelial Growth Factor D/physiology[MESH]|Vascular Endothelial Growth Factor Receptor-3/physiology[MESH] |